PURE Bioscience Overview
Latest P/E ratio for PURE Bioscience: -3.05 — see history and peer comparisons.
Get informed when a big investor buys or sells
+ Follow-3.05
The P/E ratio compares a company's stock price to its earnings per share. A lower P/E ratio may indicate that the stock is undervalued.
PURE Bioscience (PURE) currently reports a P/E ratio of -3.05. That is below the sector sector average of 25.13. Use the charts on this page to explore PURE Bioscience's P/E ratio history and peer comparisons.
PURE Bioscience's P/E ratio of -3.05 is lower than the its sector sector average of 25.13. That is roughly 112.1% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.
The P/E ratio is a valuation multiple that relates PURE Bioscience's market price to a fundamental measure such as earnings, sales, or book value. At -3.05, PURE can look expensive or cheap only in context — versus its own history, growth rate, and sector peers. Higher multiples often price in stronger expected growth; lower ones can signal value or concern.
Start with the current P/E ratio of -3.05, then check the historical chart for trend and the peer comparison chart for relative positioning. The sector average is 25.13. From there, open related valuation or income-statement pages for PURE Bioscience, and consider following PURE for alerts when major investors trade the stock.
